Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.

Songnan SuiZhiyan LiJiaxiong TanLiang WangGengxin LuoChengwu ZengOscar Junhong LuoCunte Chen Yangqiu Li

Published in: Journal of oncology (2022)

Low expression of CD5 and CD6 was associated with poor OS for TCM patients, and this may be a potential immune biomarker panel for prognostic stratification of TCM patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
chronic kidney disease
peritoneal dialysis
risk assessment
patient reported